CGRP and PTX3 as Predictors of Efficacy of Onabotulinumtoxin Type A in Chronic Migraine: An Observational Study
出版年份 2017 全文链接
标题
CGRP and PTX3 as Predictors of Efficacy of Onabotulinumtoxin Type A in Chronic Migraine: An Observational Study
作者
关键词
-
出版物
HEADACHE
Volume 58, Issue 1, Pages 78-87
出版商
Wiley
发表日期
2017-11-13
DOI
10.1111/head.13211
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Calcitonin gene-related peptide and migraine
- (2015) Nazia Karsan et al. CURRENT OPINION IN NEUROLOGY
- OnabotulinumtoxinA decreases interictal CGRP plasma levels in patients with chronic migraine
- (2015) Eva Cernuda-Morollón et al. PAIN
- OnabotulinumtoxinA treatment for chronic migraine: experience in 52 patients treated with the PREEMPT paradigm
- (2015) María Isabel Pedraza et al. SpringerPlus
- Increased VIP levels in peripheral blood outside migraine attacks as a potential biomarker of cranial parasympathetic activation in chronic migraine
- (2014) Eva Cernuda-Morollón et al. CEPHALALGIA
- Selective inhibition of meningeal nociceptors by botulinum neurotoxin type A: Therapeutic implications for migraine and other pains
- (2014) Rami Burstein et al. CEPHALALGIA
- Vascular biomarkers in migraine
- (2014) Gretchen E Tietjen et al. CEPHALALGIA
- CGRP and VIP Levels as Predictors of Efficacy of Onabotulinumtoxin Type A in Chronic Migraine
- (2014) Eva Cernuda-Morollón et al. HEADACHE
- Plasma Pentraxin 3 is a More Potent Predictor of Endothelial Dysfunction than High-Sensitive C-Reactive Protein
- (2014) Tomohiko Yasunaga et al. International Heart Journal
- Inflammatory Biomarkers in Atherosclerosis: Pentraxin 3 Can Become a Novel Marker of Plaque Vulnerability
- (2014) Akihiro Shindo et al. PLoS One
- The International Classification of Headache Disorders, 3rd edition (beta version)
- (2013) CEPHALALGIA
- An Exploratory Study of Salivary Calcitonin Gene-Related Peptide Levels Relative to Acute Interventions and Preventative Treatment With OnabotulinumtoxinA in Chronic Migraine
- (2013) Roger Cady et al. HEADACHE
- Peripheral vascular dysfunction in migraine: a review
- (2013) Simona Sacco et al. JOURNAL OF HEADACHE AND PAIN
- Efficacy, safety, and predictors of response to botulinum toxin type A in refractory chronic migraine: A retrospective study
- (2013) Kuan-Hsiang Lin et al. Journal of the Chinese Medical Association
- Interictal increase of CGRP levels in peripheral blood as a biomarker for chronic migraine
- (2013) E. Cernuda-Morollon et al. NEUROLOGY
- TWEAK: A New Player in Obesity and Diabetes
- (2013) Joan Vendrell et al. Frontiers in Immunology
- Patients profiling for Botox® (onabotulinum toxin A) treatment for migraine: a look at white matter lesions in the MRI as a potential marker
- (2013) Anja Bumb et al. SpringerPlus
- Detection of possible factors favouring the evolution of migraine without aura into chronic migraine
- (2012) G. C. Manzoni et al. NEUROLOGICAL SCIENCES
- Soluble TWEAK and PTX3 in Nondialysis CKD Patients: Impact on Endothelial Dysfunction and Cardiovascular Outcomes
- (2011) M. I. Yilmaz et al. Clinical Journal of the American Society of Nephrology
- Increased asymmetric dimethylarginine and nitric oxide levels in patients with migraine
- (2011) Ertugrul Uzar et al. JOURNAL OF HEADACHE AND PAIN
- Experience with onabotulinumtoxinA (BOTOX) in chronic refractory migraine: focus on severe attacks
- (2011) A. Oterino et al. JOURNAL OF HEADACHE AND PAIN
- Diencephalic and brainstem mechanisms in migraine
- (2011) Simon Akerman et al. NATURE REVIEWS NEUROSCIENCE
- Activation of central trigeminovascular neurons by cortical spreading depression
- (2010) XiChun Zhang et al. ANNALS OF NEUROLOGY
- OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Results From the Double-Blind, Randomized, Placebo-Controlled Phases of the PREEMPT Clinical Program
- (2010) David W. Dodick et al. HEADACHE
- Migraine as a Systemic Vasculopathy
- (2009) GE Tietjen CEPHALALGIA
- Endothelial microparticles in diseases
- (2008) Gilles N. Chironi et al. CELL AND TISSUE RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More